Q3 2017 Holdings
Filed 2017-11-08 | 113 holdings | $118.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $30.0M | 450,000 | 25.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $29.4M | 250,000 | 24.8% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $23.3M | 225,000 | 19.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $18.6M | 200,000 | 15.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONSORED ADR | 00653A107 | $4.1M | 500,000 | 3.5% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $3.4M | 650,000 | 2.9% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $2.8M | 100,000 | 2.4% |
| Blue Buffalo PET Prods Inc | COM | 09531U102 | $2.5M | 87,460,875 | 2.1% |
| Weight Watchers Intl Inc New | COM | 948626106 | $1.3M | 29,443,300 | 1.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.2M | 54,337 | 1.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $706.9K | 57,517,977 | 0.6% |
| Bank Amer Corp(BAC)Call | COM | 060505104 | $249.6K | 9,850,000 | 0.2% |
| Goldman Sachs Group Inc(GS)Call | COM | 38141G104 | $47.4K | 200,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $46.7K | 400,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $41.4K | 650,000 | 0.0% |
| Allergan PLCCall | SHS | G0177J108 | $41.0K | 200,000 | 0.0% |
| Wells Fargo Co New(WFC)Call | COM | 949746101 | $35.8K | 650,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $30.0K | 1,250,000 | 0.0% |
| International Business Machs(IBM)Call | COM | 459200101 | $29.0K | 200,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $26.1K | 700,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $24.5K | 400,000 | 0.0% |
| American Airls Group Inc(AAL)Call | COM | 02376R102 | $23.7K | 500,000 | 0.0% |
| BlackRock Inc(BLKCHF)Call | COM | 09247X101 | $22.4K | 50,000 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $21.8K | 300,000 | 0.0% |
| Metlife Inc(MET)Call | COM | 59156R108 | $20.8K | 400,000 | 0.0% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $20.3K | 250,000 | 0.0% |
| Intel Corp(INTC)Call | COM | 458140100 | $19.0K | 500,000 | 0.0% |
| Amgen Inc(AMGN)Call | COM | 031162100 | $18.6K | 100,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $18.5K | 135,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $18.5K | 1,500,000 | 0.0% |
| Incyte Corp(INCY)Call | COM | 45337C102 | $17.5K | 150,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD)Call | COM | 03152W109 | $15.1K | 1,000,000 | 0.0% |
| Morgan Stanley(MS)Call | COM NEW | 617446448 | $14.5K | 300,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $14.4K | 600,000 | 0.0% |
| Radius Health IncCall | COM NEW | 750469207 | $13.5K | 350,000 | 0.0% |
| Teradyne Inc(TER)Call | COM | 880770102 | $13.1K | 350,000 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $12.9K | 816,879 | 0.0% |
| 58 COM Inc(WUBAUSD)Call | SPON ADR REP A | 31680Q104 | $12.6K | 200,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR)Call | COM | 04269X105 | $12.3K | 1,000,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $11.6K | 120,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $11.1K | 900,000 | 0.0% |
| Medicines Co | COM | 584688105 | $11.1K | 300,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $11.0K | 2,500,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $10.6K | 700,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $9.9K | 600,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $9.7K | 75,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $9.6K | 250,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $9.5K | 115,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $9.3K | 150,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $9.3K | 300,000 | 0.0% |